Wordt geladen...
EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
The two essential requirements for pathologic specimens in the era of personalized therapies for non-small cell lung carcinoma (NSCLC) are accurate subtyping as adenocarcinoma (ADC) versus squamous cell carcinoma (SqCC) and suitability for EGFR molecular testing, as well as for testing of other onco...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Ivyspring International Publisher
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3575628/ https://ncbi.nlm.nih.gov/pubmed/23423768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.4609 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|